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Abstract
Background: Over the past 20 years, Hepatitis A notifications in Italy have been in decline. Since the beginning of
2013 however, Italy has been experiencing a foodborne hepatitis A outbreak caused by genotype IA, involving
hundreds of cases. Consumption of frozen mixed berries was deemed the potential vehicle of infection.
We aimed to investigate the spread of hepatitis A virus (HAV) in Italy through the monitoring of urban sewages
collected at Wastewater Treatment Plants (WTPs) and a subsequent comparison of environmental surveillance data
with data from the clinical surveillance performed during the epidemic.
Methods: The study covered 15 months, from July 2012 to September 2013, comprising the outbreak and the
preceding six months. Environmental surveillance consisted of the analysis of urban sewage samples collected at 19
WTPs in seven of the Italian regions most affected by the epidemic. HAV isolates were detected and typed using a
nested RT-PCR targeting the VP1/2A junction. Parallel clinical surveillance was performed by the sentinel surveillance
system for acute viral hepatitis (SEIEVA) and by the ministerial Central Task Force on Hepatitis A, established with
the purpose of determining the source of the outbreak and adopting appropriate outbreak control strategies.
Results: A total of 38/157 wastewater samples (24.2%) were positive for HAV, 16 collected in 2012 and 22 in 2013.
Several HAV strains were detected, including the IA variant implicated in the outbreak and isolated from clinical
cases over the same period. The vast majority of sequences belonged to genotype IB. Interestingly however,
although these included variants related to strains that had been involved in past Italian epidemics, none were
detected in recent clinical samples, probably due to underreporting or asymptomatic circulation. Conversely, a
number of sequences were identified in clinical samples that were not found in wastewaters.
Conclusions: The percentage of sewage samples detected as HAV-positive in this study are consistent with the
classification of Italy as a country with low/intermediate endemicity. A combined environmental/clinical surveillance
is able to provide a more complete picture of the spread of HAV and of the genotypes circulating in the population,
allowing a better understanding of changes in disease trends.
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Background
Hepatitis A virus (HAV) is an enteric picornavirus that
causes acute hepatitis in humans. It is highly resistant in
the environment, and typically transmitted via the fecal-
oral route, through exposure to contaminated foods (raw
shellfish, strawberries, etc.) or water [1].
HAV infection may be asymptomatic or may range in
severity from a mild illness lasting 1–2 weeks to a se-
verely disabling disease lasting several months to fulmin-
ant hepatitis. The severity of symptoms increases with
age. Fulminant hepatitis occurs rarely (<1% overall), but
rates are higher with increasing age and in the presence
of underlying chronic liver disease, including chronic
hepatitis B or C infection [2].
The incidence varies greatly from country to country
and is associated with socioeconomic factors. In non-
industrialized countries, and in regions where hygiene is
poor, the incidence of infection is high and the illness is
usually contracted in early childhood and is commonly
asymptomatic or mild. In these regions, a high propor-
tion of adults in the population is immune to HAV, and
epidemics are uncommon. In industrialized countries,
on the other hand, the infection is contracted primarily
by susceptible young adults. The infection is less com-
mon, but community-wide outbreaks may occur.
Hepatitis A virus is excreted in the bile and shed in
the stools of infected persons. Peak excretion occurs
during the two weeks before the onset of jaundice. Chil-
dren may excrete the virus for longer than adults, but a
chronic carrier state does not exist [2].
The disease is notifiable in Italy, which is considered
to be of low/intermediate endemicity. According to the
national legislation, laboratory-confirmed cases of hepa-
titis A virus (HAV) infection are reported by clinicians
to the local health units (LHUs) which are responsible
for the epidemiological investigation. From the LHUs,
notifications are sent to the regional health authorities
(RHAs) and from here to the Ministry of Health. How-
ever, the routine notification system does not collect
information on risk groups and risk factors associated
with hepatitis A and there is an important delay in
the transmission of the data [3]. For this reason, in
1984, a specific sentinel surveillance system for acute
viral hepatitis (SEIEVA -Sistema Epidemiologico Inte-
grato Epatiti Virali Acute) was set up in parallel with
the official notification system in Italy [4], with the
aim of monitoring trends in the incidence of the various
hepatitis types, identifying outbreaks, population groups
at risk, sources of infection and modes of transmission.
It is a voluntary sentinel surveillance system coordi-
nated by the National Centre for Epidemiology, Surveil-
lance and Health Promotion of the National Institute of
Health (Istituto Superiore di Sanità – ISS). The system
consists of a network of Local Health Units (LHUs)
located throughout Italy, where cases of acute viral hepa-
titis reported through the mandatory reporting system
are interviewed by a staff healthcare worker either face-
to-face, at the hospital of admission or, alternatively,
by telephone, to collect supplementary information on
socio-demographic characteristics, parenteral risk factors
in the six months prior to disease onset, faecal-oral risk
factors in the previous six weeks and early outcome
(occurrence of encephalopathy, fulminant disease, need
for liver transplant, and death) [4]. Currently, 77% of the
Italian LHUs cooperate with SEIEVA, covering approxi-
mately 75% of the Italian population (Tosti ME, personal
communication).
According to SEIEVA data, the incidence of hepatitis
A in Italy has decreased considerably in recent decades,
from 19 per 100,000 population in 1997, to 0.8 per 100,000
in 2012 [5].
From the beginning of 2013, Italy has been experien-
cing an outbreak of hepatitis A infection involving geno-
type IA. The outbreak, which initially appeared to have
been restricted to the provinces of Trento and Bolzano
(Trentino-South Tyrol) in northern Italy, is by now rec-
ognized as a nationwide outbreak. The increase in the
number of cases was observed mainly in the northern re-
gions of Trentino-South Tyrol, Emilia-Romagna, Lombardy,
Friuli-Venezia Giulia, Piedmont, and Veneto, as well as in
the southern region of Apulia.
Preliminary analysis identified consumption of frozen
mixed berries as a potential source of infection. This
hypothesis is strongly supported by the detection of
the outbreak HAV strain in a sample of frozen mixed
berries [6].
The Italian Ministry of Health set up a task force com-
posed of experts from the Ministry, the National Insti-
tute of Health (ISS) and the Istituto Zooprofilattico of
Lombardy and Emilia Romagna, with the aim of identify-
ing the possible source of contamination and adopt inte-
grated strategies for control. A preliminary report on the
ongoing outbreak of hepatitis A in Italy was published in
July [6].
In the present study we aimed at providing insights
into the national spread of HAV through the monitoring
of urban sewages collected at Wastewater Treatment
Plants (WTPs) in Italy, and a subsequent comparison of
environmental surveillance data with that of the clinical
surveillance performed by SEIEVA in the course of the
epidemic. The rationale behind wastewater surveillance
is based on the fact that all infected individuals, whether
symptomatic or not, shed high levels of virus in their
feces for several weeks, viruses that subsequently end
up in the environment. If a converging sewer network
serves the population of interest, it is possible to directly
monitor virus circulation in the population by examining
sewage samples.
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Methods
We analyzed sewage samples collected in the framework
of an existing WTP-based environmental network com-
prising 40 WTPs and covering the entire country (all
Italian regions), previously established for the surveil-
lance of other enteric viruses [7-9]. We selected 19 WTPs
for inclusion in this study, in seven of the regions most
affected by the ongoing outbreak: Piedmont, Lombardy,
Trentino-South Tyrol, Friuli-Venezia Giulia, Veneto, Lazio
and Apulia.
Samples were collected from July 2012 to September
2013, a period encompassing the 2013 outbreak and the
preceding six months. Due to incomplete compliance
with our monthly sampling schedule, only 157 samples
were available for analysis.
Wastewater samples were collected, handled and ana-
lyzed as previously described [9]. Briefly, untreated
wastewater samples were divided into 2 × 40 ml aliquots
upon arrival, and stored at −20°C before use. One ali-
quot was seeded with a known amount of murine noro-
virus (MNV1), added to the samples as a sample process
control. An aliquot of 20 ml was treated with 2 ml of
2.5 M glycine pH 9.5 and incubated in ice for 30 minutes;
the solution was then treated with 2.2 ml chloroform
and centrifuged at 5,000 rpm for 10 minutes. Viral nucleic
acids were extracted from 10 ml of chloroform-treated
samples, using the NucliSENS easyMAG (BioMerieux,
Marcy l’Etoile, France) semi-automated extraction system
with magnetic silica, according to the manufacturer’s in-
structions. Eluates (100 μl each) were divided into small al-
iquots and subsequently frozen at −70°C until analyzed.
The VP1/2A junction of the HAV genome was amplified
by nested RT-PCR, using 2μl of the extracted RNA, as de-
scribed elsewhere [10]. The VP1/2A junction is recognized
as one of the most variable regions of the HAV genome
and was therefore chosen for genotyping and phylogenetic
analysis. Two microliters of the extracted RNA and
22 pmol of each primer were used in a final mixture
of 25 μl using the One-Step RT-PCR Kit (Bioline, UK).
Primers used were degenerate oligonucleotides designed to
be able to amplify all HAV genotypes (universal primers).
After the first round of PCR amplification (35 cycles),
one-twentieth of the volume of the PCR product ob-
tained was used for the second PCR assay (30 cycles).
Following amplification, PCR products were purified using
a Montage PCRm96 Micro-well Filter Plate (Millipore,
Billerica, Mass). Purified PCR amplicons were subjected
to automated sequencing (Bio-Fab Research, Rome, Italy).
Inhibition in negative samples was ruled out using the
sample process control (positive PCR signal for murine
norovirus, random sampling). All standard precautions
were followed to prevent PCR contamination.
Bioinformatic analysis was performed as follows: the raw
forward and reverse ABI files were aligned and assembled
into a single consensus sequence using MEGA 6.06 soft-
ware. All sequences were submitted to BLAST analysis for
genotyping at http://blast.ncbi.nlm.nih.gov/Blast.cgi. The
phylogenetic tree was constructed based on the best fit
model of nucleotide substitution, which was selected from
among 24 models available in the software, using the mini-
mum Akaike Information Criterion (AIC). The reliability
of the phylogenetic tree was determined by bootstrap re-
sampling of 1,000 replicates. GenBank accession numbers
for the environmental sequences produced in this study
are: LK391830 to LK391867.
SEIEVA data were analyzed both by region (i.e., using
all notifications received in each of the regions) and by
catchment area, that is, considering only cases reported
by those LHUs that correspond to the geographical areas
served by the participating WTPs. Local health units
corresponding to WTP catchment areas were selected
by means of GIS.
Results
Environmental samples
A total of 157 sewage samples were tested for HAV by
the nested PCR assay described above, 76 collected in
2012 and 81 in 2013. Of these, 38 (24.2%) were positive
for HAV by PCR, all confirmed by sequencing analysis.
Results are shown in Table 1 and Figure 1.
Of the 38 positive wastewater samples, 16 were col-
lected in 2012 and 22 in 2013. The percentage of posi-
tive samples was thus 21% (16/76) in 2012 and 27%
(22/81) in 2013. Positive samples were detected in all
regions except Friuli-Venezia Giulia, in percentages ran-
ging from 2.9% to 65%. The highest figures were found in
Apulia and Lazio.
The vast majority of sequences (34/38) were classified
as genotype IB, while the remaining four sequences
belonged to genotype IA. Co-circulation of both genotypes
was observed only in 2013 (18 IB and 4 IA) however, as all
2012 samples belonged to type IB (16 samples).
The results of the phylogenetic study are presented in
Figure 2. The tree includes, in addition to the 38 study
sequences, GenBank HAV sequences corresponding to
genotypes IA, IB and IIIA (see Figure legend). Sequences
from the present study are shown as ID number fol-
lowed by the city, WTP, month and year of sample col-
lection. Samples collected in 2012 and 2013 are shown
in different colors (blue and red, respectively). The se-
quenced strains grouped into two different clusters cor-
responding to genotypes IA and IB. The vast majority of
IB sequences (32/34, of which 20 identical) formed a
well-supported cluster (93% bootstrap) along with se-
quences detected in Italy between 2000 and 2003. These
were: a.n. DQ124883 and DQ124877, identified in the
framework of a 2002/3 epidemic that started among
intravenous drug users in Umbria, in central Italy [11];
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Table 1 Participating WTPs, and PCR results on sewage samples and clinical cases notified to SEIEVA
Region WTP ID European Environment
Agency (EEA) code
City/name
of WTP
Population Equivalents
served by WTP
Municipalities
served by WTP
HAV-positive
samples/total
collected
HAV-positive sewage
samples (%)
Number of notified
clinical cases
Notified cases
from LHUs
served by WTPs
Piedmont 1 IT01000000000043 Torino/Castiglione 2,500,000 39 5/13 28% 89 34
2 IT01000000000078 Torino/Collegno 192,000 6 2/12
Lombardy 3 IT03160128000456 Milano/Nosedo 1,149,028 1 1/6 18% 144 Na
4 IT03160128000464 Peschiera/Borromeo 193,040 10 4/15 4
5 IT03160129000531 Brescia/Verziano 172,485 8 1/12 Na
Trentino South- Tyrol 6 IT21000000000008 Merano 325,338 14 0/12 2.9% 67 Na
7 IT21000000000013 Bolzano 286,682 8 1/12 13
8 IT220000000064 Trento Nord 117,629 5 0/7 50
9 IT220000000065 Trento Sud 98,945 1 0/3
Friuli Venezia Giulia 10 IT06000000000008 Trieste/Servola 154,000 1 0/4 0% 30 8
11 IT06000000000072 Trieste/Zaule 65,200 3 0/2
Veneto 12 IT05000000000212 Venezia/Campalto 109.675 1 3/15 20% 130 17
13 IT05000000000213 Venezia/Fusina 338.204 2 3/15
Lazio 14 IT12000000000321 Roma/Ostia 200.000 1 2/4 65% 74 0
15 IT12000000000304 Roma Est 705.300 3 4/7 6
16 IT12000000000317 Roma Sud 1.100.000 1 4/5 62
17 IT12000000000311 Roma/Nord 614.000 1 3/4 0
Apulia 18 IT160000000065 Bari/Est 354.600 10 3/5 55% 100 62
19 IT160000000066 Bari/Ovest 336.490 9 2/4
Total 9.012.616 124 38/157 24.2% 634 256
Na = Not available (LHUs that do not report to SEIEVA).
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and a.n AJ505624, isolated from patients with acute
hepatitis in southern Italy in 2000 and 2001 [12]. As
for the remaining two IB sequences, one (ID 1861),
collected in Turin in October 2012, was identical to
GenBank a.n. KC876797, identified during an HAV
outbreak in Denmark in the winter of 2012/2013; the
other (ID 1993), collected in Milano in April of 2013,
was closely related to sequence UNIMI-ID132/46S, ob-
tained from an Italian case notified in the same region
in June.
All four IA variants detected in sewage samples corre-
sponded to strains isolated in the same geographical area
from clinical cases notified during the ongoing outbreak.
Specifically, ID1933 (Bolzano, January 2013) and ID2018
(Turin, March 2013), were identical to the epidemic
strains a.n. KF182323 detected in the vast majority of
notified cases; in particular the same sequence was iden-
tified in clinical cases from Bolzano (strains ISS_23_29
and ISS_36_44) and Turin (ISS_59_70 and ISS_61_72).
The other two IA sequences – sample ID1983 (Bari, July
2013) and ID1988 (Bari, April 2013) – were identical to
sequence a.n. KF706407 (SCA/BAT), identified in stool
samples from another patient from the same city earlier
that year. The variant in question had been circulating
in Apulia in 2008 and 2013 as well (KF233556 and
KF706398, respectively).
Notified cases and comparison with environmental data
In the 15 months under study, from July 2012 to
September 2013, a total of 1057 cases were notified.
Of these, 634 were from the seven regions: 126 in 2012
and 508 in 2013. Data concerning the number of HAV
cases in the seven monitored regions during the study
period are shown in Table 1. The table also presents in-
formation on investigated WTPs. Lombardy, Veneto and
Apulia notified the highest number of cases (144, 130,
and 100, respectively), followed by Piedmont (89), Lazio
(74), Trentino (67), and Friuli-Venezia Giulia (30).
Of the 634 notifications, 256 (28 in 2012 and 228 in
2013) were in areas served by the studied WTPs, with
Lazio, Apulia and Trentino (68, 62, and 63 respectively)
accounting for more than 75% of these cases. Lazio
and Apulia are also the regions with the highest pro-
portion of HAV-positive sewage samples (65% and
55% respectively). A detailed comparison between HAV-
positive sewage samples and clinical notification data
from the respective WTP-catchment areas shows some
discrepancy: positive sewage samples were detected in
two WTPs, with no clinical cases notified in the corre-
sponding catchment areas (Table 1, WTP 14 and 17). On
the other hand, some cases were notified in areas where
no wastewater sample was positive for HAV (Table 1,
WTP 8–11).
Figure 1 GIS map of the participating WTPs. Figure 1 is a geographic information system (GIS) map of the WTPs under study. The map was
created using Quantum GIS (QGIS) version 2.0.1 Dufour (www.qgis.org), an open source GIS licensed under the GNU General Public Licence.
Further details on the WTPs included in the study (European Environment Agency WTP code and Population Equivalents served by each WTP)
are shown in Table 1. Bubbles show the WTP-ID followed by the number of positive samples.
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Figure 2 (See legend on next page.)
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During the outbreak period, from 1 January 2013 to 30
September 2013, 842 cases of hepatitis A were reported
to the surveillance system. Of these, 234 were sequenced
and genotyped. Two hundred and eleven isolates (90.2%)
were identified as belonging to genotype IA, 22 (9.4%) to
genotype IB, and 1 (0.4%) to genotype IIIA. In the same
period, environmental surveillance yielded completely dif-
ferent results, with 81.8% of samples identified as genotype
IB (18), and 18.2% as IA (4).
Discussion
The present report describes the first large-scale envir-
onmental HAV surveillance in Italy. Italy is considered a
country of low/intermediate HAV endemicity, with low
endemicity in northern and central Italy, where only few,
sporadic cases occur during the year, and intermediate
endemicity in a number of areas, mainly located in
southern Italy. From the beginning of 2013 however, Italy
has been experiencing a nationwide outbreak [6].
The presence of HAVs in sewage is a proven indicator
of their circulation in a given community. In the past
few years several studies have demonstrated the value of
environmental surveillance as an auxiliary tool in the
study of the epidemiology of viral pathogens [7-9,13-17].
The clinical surveillance misses mild, asymptomatic or
subclinical infections. Infected individuals shed virus
into local sewage, even though asymptomatic. The range
and diversity of viral pathogens in wastewaters are geo-
graphically specific and depend on the burden of infec-
tious diseases in the population. Wastewaters reflect the
dynamic turnover of variants, as excreted viral strains
are detectable at the treatment plant for a few days [18].
The WHO considers environmental surveillance to be
an important component of early warning systems for
poliovirus, especially in populations with high vaccine
coverage [19].
In this kind of surveillance, a single sewage sample
may represent a variable number of people depending
on the sampling site and size of the population. In our
study, we calculated that residents served by the 19
WTPs are about 4,94E + 06 to 6,22E + 06, corresponding
to 8.3% to 10,4% of the Italian population.
In Spain, studies from low endemicity areas revealed
relatively low percentages of HAV-positive samples in
urban wastewaters in recent years, ranging from 3.1% to
11% [13,20], whereas studies from high/intermediate-en-
demicity areas yielded considerably higher percentages
of HAV-positive sewage samples, up to 88% [21,22].
In our study, the percentage of HAV-positive sewage
samples, ranging from 21% prior to the epidemic to 27%
during the epidemic, is probably consistent with the
classification of Italy as a country with low/intermediate
HAV endemicity. Seroprevalence studies confirm that
Italy has moved to a low/intermediate endemicity pat-
tern, with a significant reduction in the rate of immune
subjects in the general population, especially among
those <30-40 years old.
As far as we know, only one other environmental
study on HAV in urban sewage samples was performed
in Italy [23]. The study in question, published in 1998
and based on a small number of samples, detected HAV
in 80% of samples tested, reflecting the epidemiological
situation in Italy at the time, with an HAV incidence of
19 per 100,000 population; our findings are in line with
evidence to the effect that incidence fell in recent years
(to 0.8 per 100,000 population by 2012) (SEIEVA data,
http://www.iss.it/seieva/index.php?lang=2). Similarly, in
Spain, the percentage of positive HAV samples in urban
sewage fell from 57.4% to 3.1% in 5–10 years, due to the
general improvement in sanitation [20,24].
The period studied, July 2012-September 2013, in-
cluded the six months that preceded the beginning of
the epidemic. This was done in order to allow the study
of potential changes in the circulation of the virus, both
in terms of the proportion of positive samples and of the
genotypes involved. The higher proportion of positive
sewage samples in 2013 (27%) compared to the semester
July-December 2012 (21%), was not as marked as the
rise in clinical HAV notifications (for the seven regions
studied, 508 notifications in 2013, against 126 in 2012).
Our environmental results show that HAV had been
widely circulating in the population before the 2013 out-
break, in the semester July-December 2012, a period in
which only 28 cases were notified to SEIEVA in the
(See figure on previous page.)
Figure 2 Phylogenetic tree displaying the genetic relationships between environmental, clinical and GenBank HAV isolates. The tree is
based on a partial sequence (218 nt) of the VP1/2A junction of the HAV genome. The strains identified in this study (coded in blue or red for the
years 2012 and 2013, respectively) are indicated with ID number followed by the city, month and year of sample collection. The sequence a.n.
KF182323, obtained from the first case detected in Trento, is deemed to be the prototype sequence of the Italian outbreak. Still unpublished
sequences from clinical cases are reported as sample ID followed by city, month and year of isolation. Other strains in the tree are shown by their
GenBank accession number, strain, and year of sample collection. These include IA strains (KF182323, KF201589, KF234020, KF234021, KF182323,
KF233556, KF706398, and KF706407), IB strains (DQ124883, DQ124877, AJ505624, KC876797), and one IIIA strain, KF706410, used as outgroup, to
root the phylogenetic tree. The T92 (Tamura 3-parameter) model of nucleotide substitution was used, selected as the best fit model from among
24 models available in the MEGA 6.06 software. The robustness of branching patterns was tested by 1000 bootstrap pseudo-replications; bootstrap
values >60 are indicated. The scale bar indicates nucleotide substitutions per site.
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regions under study. This could be interpreted to mean
that HAV viruses had been circulating silently, causing
asymptomatic infections. It is well known that most cases
of hepatitis A are self-limited, with non-specific symptoms
like anorexia, fever, nausea, and malaise. Among young
adults with HAV infection, 76%–97% have symptoms, and
40%–70% are jaundiced [25]. Infection in the absence of
the clinical signs and symptoms of hepatitis A is common
in children, who often have no more than a flu-like illness
or no symptoms at all. Less than 10% of children under
6 years of age have jaundice [2]. Like symptomatic patients
however, asymptomatic carriers shed the virus in their
feces, allowing the virus to enter the sewage system [26].
It should be noted that fecal shedding of HAV can, in
some cases, last for months after the resolution of symp-
toms. This can partially explain the abundance of HAV
observed in the environment.
There may also have been deficiencies in surveillance
caused by under-reporting of infections in the period
preceding the identification of the outbreak. In 2013,
after the first cases were documented in Trento and
Bolzano, the Ministry of Health (the General Direction
for Prevention and the Food Safety Authority) issued a
circular to the LHUs asking them to enhance HAV sur-
veillance and recommending that any new cases of HAV
infection be reported within 24 hours, additional epi-
demiological information be collected on potential risk
factors, and that virus genotyping and sequencing be
performed on new isolates detected. The substantial in-
crease in the number of cases of hepatitis A in 2013 may
therefore be partly attributable to changes in reporting
practices.
Another discrepancy between the environmental and
clinical surveillance concerns the genotypes detected in
the 2013 epidemic: the vast majority of clinical cases
were caused by genotype IA (90%), mainly by the “out-
break strain” KF182323, while among the HAV-positive
sewage samples collected during the epidemic, 82%
belonged to the IB genotype (18/22), and only four
belonged to the IA genotype (two of which were identi-
fied as “outbreak strains”). This raises two questions, the
first - why has clinical surveillance missed the patients
excreting IB strains in urban sewages; the second is, why
has environmental surveillance failed to identify a sig-
nificant number of IA-positive samples in wastewaters
as might have been expected in light of the outbreak. A
possible asymptomatic circulation can partially explain
the first question, as already mentioned above. Another
plausible explanation lies in the fact that, during the out-
break, samples were collected and sequenced only for
about a third of notified cases, mainly from patients hav-
ing consumed frozen berries, identified as the source of
the outbreak involving genotype IA. This could have re-
sulted in a bias leading to an underestimation of genotype
IB. As for the second question - the relatively low detec-
tion of IA in wastewaters - a possible explanation for this
finding may lie in the methodology used. We excluded a
failure of our assay to successfully amplify the outbreak se-
quence due to inadequate primer specificity, seeing that
the broad-range primers used in this study perfectly match
the IA sequence. Indeed, in a recent study on HAV in
Tunisian wastewaters, performed by our group using the
same assay, 68% of samples were found to be positive. Of
these, 98% were identified as belonging to genotype IA (10
different variants), which is also the prevalent sub-genotype
detected in clinical cases in that country (Béji-Hamza et al:
Qualitative and quantitative assessment of Hepatitis A virus
in wastewaters in Tunisia. Food Environ Virol, forthcom-
ing). An underestimation of IA strains in the present study
may have nonetheless occurred due to the fact that, while
the broad-range assay employed is able to detect all HAV
genotypes simultaneously, where more than one genotype
is present in a sample, the assay successfully amplifies
and sequences only the more prevalent genotype in terms
of concentration. Thus, the widespread distribution of
IB strains - already observed in the 2012 samples - may
have partly overshadowed the presence of IA strains. As
far as we know, similar investigations – involving a
parallel environmental/clinical surveillance - have not
been performed previously. A recent review by Vaughan
and coworker pointed out inconsistencies between envir-
onmental and clinical HAV data in a number of countries
[2]. In Mexico, for example, despite the constant detec-
tion of subtype IA in outbreaks, a study on environmen-
tal samples (estuarine waters) yielded only IB strains;
similarly, in Spain, equal circulation of HAV IA and IB
strains was observed in a clinical study, but only subtype
IB was detected in sewages. Clearly, the results of these
studies should be compared and interpreted with caution,
as the clinical and environmental studies in question
were performed in different geographical areas and at dif-
ferent times (not in parallel), often on very small sample
sizes, analyzed using different methods. The authors of the
above review concluded that different factors may signifi-
cantly affect assessment of the predominant HAV strains,
including sample collection strategies and a small sampling
size, environmental survival of viral strains and complex
patterns of HAV circulation in the world [2]. Interestingly,
however, the observations made by the above review find
confirmation in our study – a parallel (spatio-temporal)
clinical/environmental investigation, performed over a long
period of time, comprising not only the outbreak but also
the “epidemic-free” period immediately preceding it; more-
over the study analyzed a large number of environmental
samples, representative of a considerable percentage of the
Italian population, and compared the results with all the
geographically-matched clinical data available from the na-
tional surveillance system.
La Rosa et al. BMC Infectious Diseases 2014, 14:419 Page 8 of 11
http://www.biomedcentral.com/1471-2334/14/419
A detailed comparative analysis of the distribution of
positive samples by WTP and month of collection was
not feasible, unfortunately, since the number of available
wastewater samples varied significantly from one WTP to
another, with only three WTPs fully complying with our
sample-collection schedule. Generally speaking, higher
percentages of positive samples were detected in Lazio (13/
20, 65%), Apulia (5/9, 55%), and Piedmont (7/25, 28%),
followed by Veneto, Lombardy, and Trentino-South Tyrol.
Of the areas covered by the studied WTPs, Lazio and
Apulia are also the regions with the highest number of clin-
ical notifications (68 and 62 respectively).
A comparison between HAV-positive sewage samples
and clinical notification data from the corresponding
WTP-catchment areas provided evidence to the effect
that HAV was circulating in the population in the ab-
sence of clinical notifications (WTP 14 and 17), sug-
gesting that HAV had been excreted by one or more
asymptomatic patients or by symptomatic patients that
escaped notification, a testimony to the sensitivity of en-
vironmental surveillance. On the other hand, no positive
wastewater samples were detected in WTP 8–11, despite
numerous notifications in 2013. These WTPs collected
only a small number of sewage samples that year how-
ever, making it impossible to determine with any degree
of certainty whether the virus was in fact circulating
there during the period in question. It should be noted
however, that these discrepancies may also be partly at-
tributable to the fact that while the LHU that notifies
SEIEVA is the one where the diagnosis is made, this does
not necessarily coincide with the LHU corresponding to
the patient’s residence.
The vast majority of sewage samples (34, 89%)
belonged to genotype IB. Of the 34 IB sequences, 32
were closely related, of which 20 were identical. This
prevalent strain was found in 12 different WTPs in
five regions (Piedmont, Lombardy, Veneto, Lazio, and
Apulia) in both 2012 and 2013 (see Figure 2), suggesting
that its distribution is countrywide. A more distantly re-
lated IB strain (ID1993), which we collected in Milano
(Lombardy) in 2013, showed a high level of sequence
identity with another Italian strain – UNIMI-ID132/46S –
isolated from a clinical sample collected in the same region
during the outbreak.
The third IB strain (ID 1861), collected in Turin
wastewaters in October 2012, was identical to a se-
quence identified in Denmark in the winter of 2012/
2013 during a foodborne HAV epidemic that affected
northern European countries. The epidemic in ques-
tion broke out in October 2012 and was still ongoing in
2013. A case–control study in Denmark, Finland, Norway
and Sweden, combined with trace-back investigations,
identified frozen berries as the likely cause of the out-
break (Nordic Outbreak Investigation Team, 2013). Cases
identified in Finland, Norway and Sweden were infected
with the same IB genotype of the Danish sequence. Con-
ceivably, this strain may also have been circulating in
other countries, including Italy. In the absence of clinical
cases caused by the same strain however, we remain un-
able to confirm or refuse the hypothesis that this “nordic
outbreak” affected Italy as well.
All our environmental IA sequences showed 100%
identity with clinical sequences obtained from cases no-
tified during the same period and in the same area: two
were identical to the current “outbreak strain”. Of these,
one was detected in a sewage sample from Bolzano
(a province that was, along with the neighbouring Trento,
among the first to notify HAV cases); the second was iso-
lated from a sewage sample from Turin. The same se-
quence was isolated from clinical cases from Bolzano and
Turin. The other two environmental IA sequences, de-
tected in samples from Bari, were identical to sequences
isolated from clinical cases in the same city in the course
of those same months. This strain was also circulating in
the same area in 2008 and in 2011.
To summarize, our data show that:
i. The percentages of sewage samples detected as HAV-
positive in this study are probably consistent with
the classification of Italy as a country with low/
intermediate HAV endemicity;
ii. Several HAV variants were isolated from wastewater
samples, including the “outbreak strain” found in the
clinical cases reported to SEIEVA. Variants not reported
in clinical cases were also detected. On the other hand,
some variants detected in clinical samples were not
detected during wastewater surveillance. Complete
sequence identity was observed between clinical and
environmental IA HAV strains collected during the
same periods and in the same geographical areas.
iii. HAV has been circulating in Italy since before the
2013 epidemic, with a prevalent IB strain having a
countrywide distribution, and that seems not to
have had a role in the current epidemic. It seems,
therefore, that HAV strains have been circulating
silently and/or that there were deficiencies in
surveillance caused by under-reporting of infections
in the period preceding the outbreak.
Conclusion
As far as we know, this is the first large-scale environ-
mental hepatitis A surveillance in Italy, and the first to
compare data from the environmental and clinical surveil-
lance of HAV during an outbreak. Results from this study
confirm the usefulness of HAV surveillance through the
monitoring of sewer systems. A combined environmental/
clinical surveillance is able to provide a more complete pic-
ture of the spread and genetic characterization of variants
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circulating in the population, and allow comparisons with
genotypes circulating in other geographical regions. A bet-
ter understanding of changes in disease trends, afforded by
such combined studies, could also help warn of possible fu-
ture outbreaks and control them.
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